Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 14 for:    "Ovarian Seromucinous Carcinoma" | "Immunoglobulins"

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00565851
Recruitment Status : Active, not recruiting
First Posted : November 30, 2007
Last Update Posted : August 15, 2019
Sponsor:
Collaborator:
NRG Oncology
Information provided by (Responsible Party):
National Cancer Institute (NCI)